13F filerCIK 1536411 ↗
Duquesne Family Office
You are looking at Q1 2026. See the latest, Q3 2026 →
Reported value
$3.38B
−25% on the quarter before
Positions
70
31 new, 23 sold out
Top 10
55.6%
of the value
Est. gain
−$98.7M
on stocks held all quarter
Est. return
−4.6%
on those stocks since Q4 2025
Positions as of Mar 31, 2026, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2025. Striped tiles are options.
Largest buys
Since Q4 2025, sized at quarter-end prices.
- Invesco Exchange Traded Fd TCALL~$157.6MNew, 0.0% → 4.7% of the portfolio+821,000 underlying
- Ypf Sociedad Anonima~$121.5MAdded, 0.5% → 4.4% of the portfolio+2,628,972 shares
- Natera Inc~$110.4MAdded, 12.8% → 18.1% of the portfolio+552,249 shares
- STMicroelectronics~$63.5MAdded, 0.4% → 2.7% of the portfolio+1,839,325 shares
- Broadcom~$60.6MNew, 0.0% → 1.8% of the portfolio+195,955 shares
- Global X Fds~$36.2MNew, 0.0% → 1.1% of the portfolio+387,400 shares
- Caris Life Sciences Inc~$33.9MNew, 0.0% → 1.0% of the portfolio+1,894,450 shares
- Revolution Medicines Inc~$30.7MNew, 0.0% → 0.9% of the portfolio+315,860 shares
- Sandisk~$24.2MNew, 0.0% → 0.7% of the portfolio+38,155 shares
- Humana~$23.8MNew, 0.0% → 0.7% of the portfolio+137,505 shares
Largest sells
Since Q4 2025, sized at quarter-end prices.
- Select Sector SPDR Tr~$301.0MSold out, 6.7% → 0.0% of the portfolio−5,495,600 shares
- Invesco Exchange Traded Fd T~$224.9MSold out, 5.0% → 0.0% of the portfolio−1,173,925 shares
- Amazon~$144.2MCut, 3.8% → 0.3% of the portfolio−692,140 shares
- Woodward Inc~$135.9MCut, 4.0% → 2.2% of the portfolio−379,575 shares
- Alphabet~$120.5MSold out, 2.7% → 0.0% of the portfolio−385,000 shares
- Teva Pharmaceutical Inds Ltd~$105.3MCut, 4.1% → 2.1% of the portfolio−3,497,585 shares
- Bloom Energy~$81.9MCut, 1.4% → 0.5% of the portfolio−604,225 shares
- Cogent Biosciences Inc~$78.7MSold out, 1.8% → 0.0% of the portfolio−2,214,470 shares
- Coupang~$77.5MCut, 3.6% → 1.5% of the portfolio−4,105,424 shares
- MercadoLibre~$76.7MCut, 2.1% → 0.1% of the portfolio−44,383 shares
Holdings
As of Mar 31, 2026; changes in shares since Dec 31, 2025.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Natera IncCOM · shares +22% · price −12.7% | 18.1% | $612.7M | −$73.1M | ||||||
| Insmed IncCOM PAR $.01 · shares −22% · price −6.0% | 5.6% | $188.7M | −$12.1M | ||||||
| TSMCSPONSORED ADS · shares −8.8% · price +11.2% | 5.0% | $167.4M | +$16.9M | ||||||
| Ishares IncCALLMSCI BRAZIL ETF · shares 0% | 4.8% | $162.3M | — | ||||||
| Invesco Exchange Traded Fd TCALLS&P500 EQL WGT · shares New | 4.7% | $157.6M | — | ||||||
| Ypf Sociedad AnonimaSPON ADR CL D · shares +433% · price +27.8% | 4.4% | $149.6M | +$6.1M | ||||||
| Ishares IncMSCI BRAZIL ETF · shares −3.3% · price +20.8% | 3.9% | $131.9M | +$22.7M | ||||||
| Bbb Foods IncCL A COM · shares +16% · price +5.9% | 3.3% | $110.0M | +$5.3M | ||||||
| AlcoaCOM · shares +8.5% · price +24.8% | 2.9% | $99.1M | +$18.2M | ||||||
| Newamsterdam Pharma CompanyORDINARY SHARES · shares 0% · price −8.8% | 2.9% | $98.3M | −$9.4M | ||||||
| SeaSPONSORD ADS · shares +17% · price −35.1% | 2.7% | $91.1M | −$42.3M | ||||||
| STMicroelectronicsNY REGISTRY · shares +238% · price +33.2% | 2.7% | $90.3M | +$6.7M | ||||||
| Woodward IncCOM · shares −64% · price +18.4% | 2.2% | $75.6M | +$11.8M | ||||||
| Teva Pharmaceutical Inds LtdSPONSORED ADS · shares −60% · price −3.5% | 2.1% | $71.6M | −$2.6M | ||||||
| RokuCOM CL A · shares +29% · price −12.8% | 2.1% | $71.0M | −$8.1M | ||||||
| BroadcomCOM · shares New | 1.8% | $60.6M | — | ||||||
| State Str SPDR S&P 500 ETF TCALLTR UNIT · shares 0% | 1.7% | $58.5M | — | ||||||
| CoupangCL A · shares −61% · price −20.0% | 1.5% | $50.4M | −$12.6M | ||||||
| Option Care Health IncCOM NEW · shares +7.0% · price −15.5% | 1.5% | $50.3M | −$8.6M | ||||||
| AmazonCALLCOM · shares +100% | 1.2% | $41.7M | — | ||||||
| CRH plcORD · shares −21% · price −15.8% | 1.2% | $39.7M | −$7.4M | ||||||
| Figure Technology SolutioCOM CL A · shares −25% · price −16.9% | 1.2% | $39.1M | −$7.9M | ||||||
| Global X FdsGB MSCI AR ETF · shares New | 1.1% | $36.2M | — | ||||||
| Caris Life Sciences IncCOM · shares New | 1.0% | $33.9M | — | ||||||
| Restaurant Brands Intl IncCOM · shares −62% · price +8.3% | 0.99% | $33.6M | +$2.6M | ||||||
| Total 70 positions | 100% | $3.38B | −$98.7M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2025 to Q1 2026: 35 stocks held throughout, down $98.7M (−4.6%).
- Ishares Inc+$22.7M+21%
- Alcoa+$18.2M+25%
- TSMC+$16.9M+11%
- Woodward Inc+$11.8M+18%
- Adma Biologics Inc6:1 split+$9.0M+196%
- Stubhub Hldgs Inc−$10.0M−54%
- Insmed Inc−$12.1M−6%
- Coupang−$12.6M−20%
- Sea−$42.3M−35%
- Natera Inc−$73.1M−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | $4.47B−14% | SEC ↗ |
| Q2 2026 | Aug 14, 2026 | $5.21B+54% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $3.38B−25% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $4.49B+11% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $4.06B−0% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $4.07B+33% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $3.06B−18% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $3.72B+26% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.95B+1% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.92B−34% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $4.39B+31% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $3.35B+20% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $2.79B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $2.87B+25% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $2.31B+14% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $2.02B+15% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $1.76B+28% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.38B−40% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.31B−16% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.76B−10% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $3.08B−24% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 (amended) | $4.04B−11% | SEC ↗ |
| Q1 2021 | May 17, 2021 (amended) | $4.53B+22% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.71B+8% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $3.44B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $3.27B+32% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $2.47B−28% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $3.41B+33% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.57B−24% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.37B−2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $3.45B+100% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $1.73B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $2.10B+2% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.07B+14% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.81B−9% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.98B−10% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $2.20B+18% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.87B+22% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.52B+49% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $1.03B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $1.13B+30% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $870.7M−35% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $1.34B | SEC ↗ |